WIRB-Copernicus Group Acquires ePharmaSolutions

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. Based near Philadelphia, PA, ePS is a provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials. Its proprietary solutions, including a cloud-based enterprise Clinical Trial Portal (CTP) and Electronic Trial Master File (eTMF), are used by 350,000 clinical research professionals in 130 countries. WCG noted that the addition of ePS expands WCG’s eClinical offerings for improving clinical trial start-up and management.

Like the other companies within WCG, ePS will continue to operate independently and retain both its leadership and brand. WCG will support ePharmaSolutions as it continues to expand its platform solution with access to capital, complementary clinical expertise, corporate support, and integration of its technologies within the WCG family of companies.